Not finding it? Sign in to also search OpenAlex live.
-
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry2020 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Vince B. C. Biemans, Jasmijn A M Sleutjes, Annemarie Charlotte de Vries, Alexander G L Bodelier, Gerard D. H. Dijkstra, Bas Oldenburg, +14 more
88citations -
Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry2025 United European Gastroenterology Journal article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Myrthe R Naber, Andrea E. van der Meulen‐de Jong, Philip W. Voorneveld, Suzanne H. C. Veltkamp, Adriaan A. van Bodegraven, Alexander G L Bodelier, +10 more
3citations -
Tofacitinib fails to prevent T cell transfer colitis in mice but ameliorates disease activity2023 Scientific Reports article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Sudheendra Hebbar Subramanyam, Judit Turyne Hriczko, Angeliki Pappas, Angela Schippers, Kim Ohl, Klaus Tenbrock
3citations -
MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factors2022 JCI Insight article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Rachel E. Brown, Justin Jacobse, Shruti A. Anant, Koral M. Blunt, Bob Chen, Paige N. Vega, +14 more
16citations -
Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract2022 Nature Communications article Biochemistry, Genetics and Molecular Biology Gut microbiota and health Open access
Jianan Zhang, Morgan E. Walker, Katherine Z. Sanidad, Hongna Zhang, Yanshan Liang, Ermin Zhao, +25 more
113citations -
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Severine A.R.A. Vermeire, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, Angela de Haas, +1 more
7citations -
Proton pump inhibitors and gut microbiota dysbiosis: insights into the pathogenesis of ulcerative colitis2025 Frontiers in Microbiology article Biochemistry, Genetics and Molecular Biology Gut microbiota and health Open access
Feng Cao, Shuo Liu, Yanwei Liu, Yong Xin Qi, Yunsheng Cheng, Yong Wang, +1 more
7citations -
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study2022 Clinical Gastroenterology and Hepatology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, Vince B. C. Biemans, Marijn Caroline Visschedijk, Frank Hoentjen, Annemarie de Vries, Adriaan A. van Bodegraven, +47 more
51citations -
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry2022 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, Fiona D M van Schaik, Alexander G L Bodelier, Marijn Caroline Visschedijk, Annemarie Charlotte de Vries, Cyriel Y. Ponsioen, +13 more
28citations -
Soluble mucosal addressin cell adhesion molecule 1 is a biomarker for pediatric ulcerative colitis2026 Molecular and Cellular Pediatrics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Moritz Muschaweck, Christian Gutbier, Gernot Sellge, Angeliki Pappa, Tobias G. Wenzl, Karim Hamesch, +2 more
0citations -
Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study2024 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Emilie van Lingen, Sam Nooij, Elisabeth M. Terveer, Emily M. Crossette, Amanda Prince, Shakti K. Bhattarai, +10 more
25citations -
Dynamics of Gut Microbiota After Fecal Microbiota Transplantation in Ulcerative Colitis: Success Linked to Control of Prevotellaceae2024 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Susanne Pinto, Dominika Šajbenová, Elisa Benincà, Sam Nooij, Elisabeth M. Terveer, Josbert J. Keller, +3 more
20citations -
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
18citations -
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edward V. Loftus, Severine A.R.A. Vermeire, Brian G. Feagan, Franck‐Olivier Le Brun, Alessandra Faria Oortwijn, Ulrik Moerch, +2 more
12citations -
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Iris Dotan, Brian G. Feagan, Virginia Taliadouros, Alessandra Faria Oortwijn, Christine Rudolph, Angela de Haas, +4 more
10citations -
OP07 Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
5citations -
DOP45 Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Kana Matsuoka, Mark Löwenberg, Mathurin Fuméry, Yoshie Takatori, Y Fujitani, Alessandra Faria Oortwijn, +3 more
0citations -
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial2022 The American Journal of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Silvio Danese, Marc Ferrante, Brian G. Feagan, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥, William J. Sandborn, +10 more
31citations -
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE2023 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, Severine A.R.A. Vermeire, Christian Maaser, Silvio Danese, +8 more
22citations -
Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis2023 Journal of Proteome Research article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Florent Clerc, Karli R. Reiding, Noortje de Haan, Carolien A. M. Koeleman, Agnes L. Hipgrave Ederveen, Natalia Manetti, +3 more
18citations -
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial2022 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, +10 more
15citations -
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study2024 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +9 more
14citations